Parallel's historical operating platform combined retail distribution with cultivation and manufacturing across three state-regulated cannabis markets. The assets transferred in July 2026 included 56 retail locations and three production facilities, providing an established regional footprint rather than a new-market rollout.

That footprint included Surterra Wellness in Florida, Goodblend in Texas, and New England Treatment Access in Massachusetts. At the transaction date, Goodblend was one of three active licensed operators in Texas; the specified equity interests and operating assets were acquired by CDXX TransCo, LLC through consensual strict foreclosure.

Parallel's business is organized around regulated regional cannabis markets and the retail brands serving them. Its official timeline records licensing, dispensary openings and branded-product launches, showing how market permissions and individual store networks shaped expansion.

The company also describes community programs focused on cannabis access and participation in the industry. These include partnerships supporting medical-marijuana certifications and education for entrepreneurs, complementing its cultivation, manufacturing and retail activities.

Parallel's historical cannabis business combined cultivation and manufacturing with branded retail distribution in Florida, Texas, and Massachusetts. Its regional operating portfolio included Surterra Wellness, Goodblend, and New England Treatment Access, connecting state-licensed production facilities with consumer-facing dispensaries and pickup locations.

On July 27, 2026, CDXX TransCo, LLC acquired specified equity interests and assets associated with those operations through consensual strict foreclosure. The transferred footprint included 43 Florida dispensaries, ten Texas retail or pickup locations, three Massachusetts dispensaries, and one cultivation and production facility in each state.